title: Nourkrin: objective and subjective effects and tolerability in persons with hair loss.
abstract: This randomized, double-blind, placebo-controlled study was designed to investigate the efficacy and tolerability of Nourkrin, a new natural agent for the treatment of hair loss based on marine proteins, and minerals and vitamins. Fifty-five subjects with hair loss of different aetiologies participated in the 6-month blinded phase of the study. Objective assessments showed a significant positive effect of treatment on hair growth. Intake of the active preparation for a further 6 months in an open phase indicated a subjective further improvement in hair growth. Exposure of the patients previously treated with placebo to the active preparation for 12 months gave similar results. Tolerability was good and no side-effects were reported. Nourkrin may provide an alternative to pharmacotherapy for the treatment of hair-loss problems in individuals with androgenetic alopecia.
authors.affiliation: ETC Research and Development, Oslo, Norway. erlingthom@etc.as
authors.forename: E
authors.initials: E
authors.lastname: Thom
mesh_terms: D000328:Adult; D000505:Alopecia / Q000188:drug therapy*; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D006197:Hair / Q000187:drug effects / Q000254:growth & development; D006203:Hair Preparations / Q000494:pharmacology*; D006801:Humans; D007039:Hypotrichosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D017060:Patient Satisfaction; D010919:Placebos; D011506:Proteins / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D004338:Drug Combinations; D006203:Hair Preparations; D010919:Placebos; D011506:Proteins; C517859:nourkrin